Capitalmind Mashup – a weekly newsletter to bring you a platter of publications over the past few days. All content shared here can be accessed by users except #Premium limited to only Capitalmind Premium Subscribers. Catch all the previous mashups here.
Hope you have a good time reading this MashUp. Do share your views in the comment section below.
On Slack: 8% GDP Growth Milestone? Black Money Prosecution, Brexit on Track, Forex Reserves Down, Mopeds Gain Speed, Penny Stocks Scam, Possible President Impeachment, Speeding Car Hitting A Wall, The Dollar Problem and much more…
On Slack: 1990s Back to Markets, Biggest-ever Layoffs, Challenge Election Results, E-commerce Losses, India’s GDP Revised, Moneymaking Machine, Sterilise Liquidity and more….
Introducing the Strong Stock Portfolio: 30 Stocks That Show Promise
Bond Baba: Those Long Bond Funds Gave Us a 24% Return, And It Might Just Last Longer
Portfolio: Adding another PSU Firm Into Momentum Portfolio
Portfolio: Buying More in Long Term, Averaging Down
Macronomics: What is Reverse Repo and How Are Banks Dealing With Too Much Money?
Bond Baba: Why Are There Two 10-Year Bonds With Different Yields?
Exiting Capital Mind Monsoon Portfolio – Returns 20% in 4 Months
Macronomics: The Strange Case of the Highest LIBOR Since 2009
Portfolio: Exiting Aarti Drugs and GSFC From Momentum
StratOptions: IV spike post Surgical Strikes helps us score a quick 2.63%
Using Ratio Spreads to trade earnings: A live-example on INFY
L&T Reports 41% Growth In PAT Excluding Its Divestment In Insurance Biz
Results: Nifty 50 Underperform Again; 48 Companies, Aggregate Profit Down 6%
Wockhardt’s UK Based Step-down Subsidiary CP Pharmaceuticals Re-Slapped With A USFDA Warning Letter
Jubilant HollisterStier Recalls Misbranded Allergenic Extract
Amerisource Health Services Recalls 40 Lakh Antidepressant Tablets Manufactured By Cadila Healthcare
Cipla Makes $15 Million Profit By Selling Stake in Chase Pharmaceuticals, Could Make $146M More
Strides Acquires PediaCare®From Moberg Pharma For US $5 Million
Aurobindo Pharma’s Arrow Generiques To Acquire Select Assets From Teva